The pharma industry is under increasing pressure to reduce its environmental impact while maintaining the highest standards of product safety. Cleanrooms, though essential, are among the most resource-intensive parts of a facility.
In this article, AES Cleanroom Technology explores how modular cleanroom design is helping to address sustainability challenges by reducing waste, optimising energy use and creating a foundation for integrating next-generation technologies.
Sustainability pressures reshaping pharma
The pharmaceutical industry is currently sitting at a unique crossroad: it is charged with developing life-changing therapies, but it also needs to operate some of the most resource-intensive facilities in the world. As sustainability rises up the global agenda, the pharmaceutical sector faces growing scrutiny over the environmental footprint of its operations, particularly its infrastructure.
This pressure comes from every direction:
- Investors are increasingly directing capital toward businesses with a credible sustainability story, with strong ESG performance potentially reducing risks, enhancing brand value and improving patient and investor trust.
- Patients increasingly support healthcare options that balance clinical efficacy and environmental considerations.
- Regulators are introducing more demanding requirements. In Europe, for example, the Corporate Sustainability Reporting Directive (CSRD) now requires even non-EU companies with operations in the European Union to disclose a wide spectrum of ESG metrics, including greenhouse gas emissions.
- Within the industry itself, there is a growing recognition that a strong sustainability agenda can help attract and retain top talent in a competitive labour market.
As a result, many pharmaceutical companies are now reinforcing their commitment to sustainability by setting and publicly disclosing climate-related goals and targets, aligning their strategies with global initiatives such as the Science Based Targets initiative (SBTi) and the United Nations Sustainable Development Goals.
Against this backdrop, pharmaceutical companies are reviewing every aspect of their operations to identify opportunities for improvement. One area with particular significance is the cleanroom. While indispensable to modern manufacturing, cleanrooms are also some of the most resource-intensive spaces in a facility, making them a natural focus for ESG-driven innovation.
Addressing the challenges of traditional cleanrooms
Cleanrooms have always been central to pharmaceutical production. These controlled environments ensure drug products are produced under conditions that protect patient safety, product purity and therapeutic efficacy. However, the very features that make cleanrooms indispensable also make them difficult to align with modern sustainability expectations.
Maintaining sterile conditions requires powerful heating, ventilation and air conditioning (HVAC) systems that run continuously and consume large amounts of energy. In fact, HVAC systems are often responsible for the majority of cleanroom energy use. Rigorous cleaning protocols introduce additional pressures: the frequent use of cleaning chemicals, combined with water-intensive washdown procedures, generates both waste and high water demand.
Taken together, these realities make traditional cleanrooms some of the most resource-heavy spaces in pharmaceutical development and manufacturing. Addressing their environmental footprint has therefore become a priority for companies seeking to meet ESG goals while maintaining the highest standards of compliance and product quality.
The very features that make cleanrooms indispensable also make them difficult to align with modern sustainability expectations
Cleanrooms designed with sustainability in mind
As sustainability becomes a central priority in pharmaceutical production, cleanrooms must evolve. Facilities now need environments that deliver uncompromising contamination control while also reducing energy and resource consumption.
Modular cleanroom design offers a pathway to achieving this balance. Unlike conventional cleanrooms built entirely on-site, modular cleanrooms are assembled from prefabricated components manufactured under controlled conditions. This approach shortens installation timelines, improves quality consistency and creates facilities that can be expanded, reconfigured, or upgraded far more easily than fixed builds.
As components are produced to precise specifications, material offcuts and on-site waste are also minimised with a modular approach. When facilities adapt to new processes, modules can also often be repurposed rather than discarded, reducing waste further and supporting circularity in construction.
Another important advantage of modular cleanroom design is the increased safety it provides. Modules are precision-engineered and prevalidated in controlled factory conditions, ensuring consistent quality, reducing on-site risks and supporting long-term reliability.
Traditional air management systems are often oversized
Supporting the new era of sustainable technologies
Beyond the build itself, modular cleanrooms offer an ideal framework for the next generation of sustainable technologies. Their adaptable architecture makes it possible to integrate advanced systems from the outset, ensuring efficiency is designed in rather than retrofitted later. For pharmaceutical companies looking to meet ambitious sustainability goals, this means cleanrooms can become platforms for innovation, incorporating smarter airflow strategies, intelligent filtration and emerging digital tools:
Optimised airflow - Traditional air management systems are often oversized, running continuously at high volumes to guarantee compliance. While modelling tools such as computational fluid dynamics (CFD) can be applied to traditional cleanrooms to optimise airflow, modular cleanrooms provide a distinct advantage: they are designed for adaptability. This makes it easier to translate simulation insights directly into construction, allowing HVAC systems to be right-sized from the outset. Consequently, pharma companies can reduce energy demand and operating costs while still maintaining strict contamination control.
Advanced filtration systems - Filtration is critical for protecting product integrity,
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cleanroom Technology.
Subscribe now Already a subscriber? Sign in here.